Home > Search: Naloxone Injection

• Search Results

Search Results Get Your Free Credit Report Right Now! Zip Code: Join our discussion forums! Providers join our directory! General Topics A-Z Conditions Treatments Medications Fitness Nutrition Anatomy Travel/Destinations Other Topics From the West From the East

Main Topic Area Naloxone Injection All Topic Areas 1 - 10 of 907  more >> Naloxone Naloxone Injection Narcan Dicyclomine Injection Antispas Injection Bentyl Injection Di-Spaz Injection Dibent Injection Dilomine Injection Or-Tyl Injection Articles 1 - 1 of 1 Antagon Injection Consumer Information Antagon is used to inhibit premature ovulation in women undergoing fertility procedures. Women who have experienced a hypersensitivity reaction to gonadotropin-releasing hormone (GnRH) or any other GnRH-type drug. Women who suspect or know they are pregnant. A physician specializing in fertility treatment should prescribe Antagon. Before starting treatment with Antagon, pregnancy must be ruled out. General Precautions with Antagon: Patients with hypersensitivity to GnRH should be closely... U.S. Food and Drug Administration News 1 - 5 of 304  more >> Injection Drug Use Fueling Spread Of HIV In Mauritius MedicalNewsToday - Mon, 26 Feb 2007 09:00 EST FDA Approves Astellas' Vaprisol(R) For The Treatment Of Hypervolemic Hyponatremia MedicalNewsToday - Sat, 03 Mar 2007 08:00 EST International Narcotics Control Board Hindering HIV/AIDS Control Efforts, Should Be Independently Reviewed, Report Says MedicalNewsToday - Mon, 05 Mar 2007 12:00 EST More Frequent Participation In Needle-Exchange Programs Does Not Increase Risk Of HIV Infection, Study Says MedicalNewsToday - Fri, 02 Mar 2007 06:00 EST New Storage Instructions Approved For BYETTA® MedicalNewsToday - Sun, 25 Feb 2007 08:00 EST Clinical Trials 1 - 5 of 325  more >> Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9 ClinicalTrials.gov Identifier: NCT00000344 - Active, not recruiting Opioid-Related Disorders Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1 ClinicalTrials.gov Identifier: NCT00078130 - Active, not recruiting Opioid-Related Disorders Abuse Potential of Parenteral Buprenorphine/Naloxone in Non-Dependent Opioid Abusers - 3 ClinicalTrials.gov Identifier: NCT00134875 - Active, not recruiting Opioid-Related Disorders Buprenorphine/Naloxone Versus Clonidine for Inpatient Opiate Detoxification - 1 ClinicalTrials.gov Identifier: NCT00032955 - Active, not recruiting Heroin Dependence; Morphine Dependence; Substance Withdrawal Syndrome Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1 ClinicalTrials.gov Identifier: NCT00032968 - Active, not recruiting Heroin Dependence; Morphine Dependence; Substance Withdrawal Syndrome

GoldBambooTM Your Integrative Health and Wellness Resource November 28, 2009

email this page   |    print this page   |    bookmark this page   |    feedback on this page Page Updated: January 17, 2009

Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.